Results 101 to 110 of about 51,886 (205)

Observational and Genetic Association of Myelodysplastic Syndromes (MDS) and Autoimmune Diseases in Adults. [PDF]

Mediators Inflamm
Li Q, Guo Y, Xiao G, Song X, Wei Y, Gao W, Feng G, Zuo X, Shi X, Zhao H, Hu Y, Rebetz J, Semple E, Guo L, Semple JW, Peng J, Xu S.   +16 more
europepmc   +1 more source

TP53-mutated myelodysplastic syndromes and acute myeloid leukemia: a 3 comprehensive overview of targeted approaches. [PDF]

Front Oncol
Deshpande S, Li WF, Song J, Forsberg M, Cerchione C, Martinelli G, Konopleva M.   +6 more
europepmc   +1 more source

UBE2O as a key regulator of drug-induced erythropoiesis in the context of myelodysplastic syndromes. [PDF]

Blood Adv
Maffeo B, Panuzzo C, Savi A, Itri F, Piccioli S, Danzero AC, Maglione A, Marini S, Voso MT, Fava C, Bracco E, Pergolizzi B, Cilloni D.   +12 more
europepmc   +1 more source

Improved survival after acute graft-versus-host disease diagnosis in the modern era [PDF]

, 2017
et al.,, Hayashi, Robert J, Vig, Ravi
core   +1 more source

Platelet glycosylation in myelodysplastic syndromes correlates with disease severity. [PDF]

Blood Adv
Rosenbalm KE, Wong TL, Hoang D, Andersen VL, Steinhardt G, Zheng S, Griffiths EA, Gu T, Hoffmeister KM, Lau JTY, Nemeth MJ.   +10 more
europepmc   +1 more source

Management of iron overload in myelodysplastic syndromes: combined deferasirox and deferoxamine in a patient with liver disease [PDF]

, 2016
AVILIA, SIMONA, CATALANO, LUCIO, CERCHIONE, CLAUDIO, Cerciello, Giuseppe, DELLA PEPA, ROBERTA, Pane, Fabrizio, PICARDI, MARCO, PUGLIESE, NOVELLA   +7 more
core   +1 more source

Myelodysplastic syndromes: A primary care perspective. [PDF]

S Afr Fam Pract (2004)
Naidoo K, Parasnath S.
europepmc   +1 more source

Advances and Challenges in the Management of Myelodysplastic Syndromes. [PDF]

Cancers (Basel)
Stempel JM, Kewan T, Zeidan AM.
europepmc   +1 more source

Cell Lines in Myelodysplastic Syndromes/Neoplasms (MDS) Research: A Review of Existing Models and Their Applications. [PDF]

Int J Mol Sci
Maślińska-Gromadka K, Palusińska M, Łuczak JW, Skopek R, Kraj L, Schenk T, Zelent A, Szymański Ł.   +7 more
europepmc   +1 more source

Identification and validation of the dopamine agonist bromocriptine as a novel therapy for high-risk myelodysplastic syndromes and secondary acute myeloid leukemia [PDF]

, 2015
Liberante, Fabio Giuseppe, McMullin, Mary-Frances, Mills, Kenneth Ian, Pouryahya, Tara, Zhang, Shu-Dong   +4 more
core   +1 more source